Both gut microbiota and cytokines act to atherosclerosis in ApoE−/− mice
Authors:
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Microbial Pathogenesis
- Vol. 138, 103827
Abstract
No abstract availableKeywords
Funding Information
- The National Key Stone Basic Research Program (973 Program) of China (2013CB531401)
- National Human Genetic Resources Sharing Service Platform (2005DKA21300)
- Sanming Project of Medicine in Shenzen Municipality (SZSM201512005)
This publication has 39 references indexed in Scilit:
- Linking the Human Gut Microbiome to Inflammatory Cytokine Production CapacityCell, 2016
- Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targetsCytokine & Growth Factor Reviews, 2015
- Symptomatic atherosclerosis is associated with an altered gut metagenomeNature Communications, 2012
- Progress and challenges in translating the biology of atherosclerosisNature, 2011
- The immune system in atherosclerosisNature Immunology, 2011
- The immune system and the gut microbiota: friends or foes?Nature Reviews Immunology, 2010
- Th17 Cytokines and the Gut Mucosal BarrierJournal of Clinical Immunology, 2010
- Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patientsProceedings of the National Academy of Sciences, 2008
- Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice.Journal of Clinical Investigation, 1998
- Reduction of atherosclerosis in mice by inhibition of CD40 signallingNature, 1998